Elevance Health (ELV) Institutional Ownership 2025 - MarketBeat

5 days ago · Of the 1,655 institutional investors that purchased Elevance Health stock in the last 24 months, the following investors and hedge funds have bought the highest volume of …

22%
OFF

Elevance Health Inc Stock Ownership - Who Owns Elevance Health?

2 weeks from now

Elevance Health (NYSE: ELV) is owned by 87.22% institutional shareholders, 2.57% Elevance Health insiders, and 10.21% retail investors. Vanguard Group Inc is the largest individual …

wallstreetzen.com

$35593248.86
OFF

Elevance Health (ELV) Insider Trading Activity 2025 - MarketBeat

2 weeks from now

Jan 6, 2025 · Insiders have sold a total of 72,811 Elevance Health shares in the last 24 months for a total of $35,593,248.86 sold. Which members of congress are trading Elevance Health? …

marketbeat.com

$625.00
OFF

Elevance Health: Buy Rating Affirmed Amid Attractive Valuation …

2 weeks from now

Oct 16, 2024 · Analyst Michael Ha of Robert W. Baird maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $625.00.. Michael Ha has given his Buy …

businessinsider.com

$520.00
OFF

Analyst Ratings For Elevance Health - Nasdaq

2 weeks from now

Oct 18, 2024 · 11 analysts have shared their evaluations of Elevance Health (NYSE:ELV) ... Buy: $520.00: $620.00: Ben Hendrix: RBC Capital ... Investors who use analyst ratings should note …

nasdaq.com

$562
OFF

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

2 weeks from now

Dec 4, 2024 · Elevance Health, Inc. saw significant share price movement during recent months on the NYSE, rising to highs of US$562 and falling to the lows of US$394. Some share price …

yahoo.com

$88647933952
OFF

Thinking Of Buying Elevance Health (ELV)? Here's What You Need …

2 weeks from now

2 hours ago · The company is based in Indianapolis and has 104,900 full time employees. Its market capitalization is $88,647,933,952. Elevance Health currently offers its equity investors …

marketinference.com

88%
OFF

Elevance Health Is An Undervalued Healthcare Juggernaut

2 weeks from now

Dec 26, 2024 · Elevance Health is currently undervalued, offering investors a very good margin of safety. The company trades at a FWD P/E ratio of 11.35, or 8.88% forward earnings yield. On …

seekingalpha.com

$114
OFF

Here's Why You Should Add Elevance Health Stock To Your Portfolio

2 weeks from now

Oct 9, 2024 · Elevance Health — with a market cap of $114.2 billion — is a major health benefits company. Courtesy of solid prospects, this Zacks Rank #2 (Buy) stock is worth adding to your …

nasdaq.com

$32.91
OFF

Elevance Health (ELV) Upgraded To Buy: What Does It Mean For

2 weeks from now

Oct 11, 2023 · Earnings Estimate Revisions for Elevance Health For the fiscal year ending December 2023, this health insurer is expected to earn $32.91 per share, which is a change of …

nasdaq.com

$551.00
OFF

Elevance Health: Strong Financial Performance And Strategic Value ...

2 weeks from now

Oct 23, 2024 · In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $551.00. Erin …

businessinsider.com

$5.99
OFF

Elevance Health (ELV) Earnings Date And Reports 2025 - MarketBeat

2 weeks from now

2 days ago · Elevance Health (NYSE:ELV) has a recorded net income of $5.99 billion. ELV has generated $27.43 earnings per share over the last four quarters. ... Why Earnings Make It a …

marketbeat.com

FAQs about Elevance Health (ELV) Institutional Ownership 2025 - MarketBeat Coupon?

Should you buy Elevance health (ELV – research report)?

Analyst Michael Ha of Robert W. Baird maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $625.00. Michael Ha has given his Buy rating due to a combination of factors that suggest a positive long-term outlook for Elevance Health. ...

Why did Elevance health acquire ELV?

These acquisitions help Elevance Health expand its market presence, diversify revenue streams, and strengthen its offerings in Medicare Advantage and Medicaid services. Premium rate increases and product expansions will continue to support ELV’s growth trajectory. ...

Did Elevance health (ELV) miss earnings estimate?

In the previous quarter, Elevance Health (NYSE:ELV) missed the analysts' consensus estimate of $9.66 by $1.29 with a reported earnings per share (EPS) of $8.37. Learn more on analysts' earnings estimate vs. ELV's actual earnings. How can I listen to Elevance Health's earnings conference call? ...

Should you buy Elevance Health (EH)?

These factors collectively suggest that Elevance Health is well-positioned for continued growth and profitability, making it an attractive investment opportunity. In another report released today, Bernstein also maintained a Buy rating on the stock with a $549.00 price target. ...

Is Elevance health a good stock to buy?

Finally, the balance sheet is acceptable for the healthcare industry. The company currently holds $7.86B in cash but is currently owning $2.1B of debt payable in less than a year. The company’s total long-term debt stands at $24.68. Elevance Health is currently undervalued, offering investors a very good margin of safety. ...

How did Elevance perform in Q2?

The power of Elevance’s diversified business was evident in the second quarter results. The firm reported 2Q 2024 diluted EPS of $9.85, up 26% year-over-year. Health Benefits showed resilience in Q2 with a strong growth in ACA health plan membership. In Health Services, Carelon services delivered a robust growth in operating revenue. ...